VA
CVS icon

Vident Advisory’s CVS Health CVS Stock Holding History

Vident Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Buy
145,635
+66,195
+83% +$5.91M 0.11% 177
2026
Q1 		$5.71M Sell
79,440
-14,601
-16% -$1.12M 0.05% 324
2025
Q4 		$7.46M Buy
94,041
+41,023
+77% +$3.23M 0.07% 239
2025
Q3 		$4M Buy
53,018
+2,313
+5% +$159K 0.04% 364
2025
Q2 		$3.5M Buy
50,705
+31,439
+163% +$2.06M 0.04% 357
2025
Q1 		$1.31M Sell
19,266
-13,967
-42% -$836K 0.02% 626
2024
Q4 		$1.49M Sell
33,233
-48,983
-60% -$2.75M 0.03% 499
2024
Q3 		$5.17M Buy
82,216
+56,750
+223% +$3.31M 0.13% 152
2024
Q2 		$1.5M Sell
25,466
-346,517
-93% -$21.7M 0.04% 462
2024
Q1 		$29.7M Buy
371,983
+48,785
+15% +$3.73M 0.62% 28
2023
Q4 		$25.5M Sell
323,198
-397
-0.1% -$28.3K 0.64% 16
2023
Q3 		$22.6M Buy
+323,595
New +$22.9M 0.7% 16

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vident Advisory's CVS Position: Q2 2026 in Review

Vident Advisory increased its CVS Health (CVS) stake by 83% in Q2 2026, buying an estimated $5.91M and bringing the position to 145,635 shares worth $15.1M. The position accounts for 0.11% of the portfolio, ranked #177.

Vident Advisory first reported a position in CVS in Q3 2023 and has held it in 12 quarters since. The position peaked at $29.7M in Q1 2024. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Vident Advisory held 145,635 shares of CVS Health worth $15.1M as of Q2 2026.
  • Vident Advisory bought 66,195 CVS Health shares in Q2 2026, an estimated $5.91M.
  • CVS Health made up 0.11% of Vident Advisory's portfolio in Q2 2026, its #177 holding.
  • Vident Advisory first reported a position in CVS Health in Q3 2023 and has held it in 12 quarters since.
  • Vident Advisory's CVS Health position peaked at $29.7M in Q1 2024.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.